Stock listing
LLY Stock Price, News, Filings & Events — Eli Lilly And Company
Selected listing: LLY · NYSE · USD · US
This page tracks Eli Lilly And Company's LLY:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LLY:NYSE. LLY:NYSE is the stock-level entry point for investors researching Eli Lilly And Company, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Eli Lilly and Company, trading under the ticker LLY, is a prominent public company based in America with a market capitalization of approximately $1.11 trillion. The company focuses on developing innovative pharmaceuticals to improve patient outcomes across various therapeutic areas. Eli Lilly is recognized for its commitment to research and development in the healthcare sector.

- Ticker
- LLY:NYSE
- Asset type
- Stock
- Market cap
- $1.05T
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE
- Currency
- USD
Eli Lilly And Company LLY:NYSE stock context
This page tracks Eli Lilly And Company's LLY:NYSE listing on NYSE in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LLY:NYSE. LLY:NYSE is the stock-level entry point for investors researching Eli Lilly And Company, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Eli Lilly and Company, trading under the ticker LLY, is a prominent public company based in America with a market capitalization of approximately $1.11 trillion. The company focuses on developing innovative pharmaceuticals to improve patient outcomes across various therapeutic areas. Eli Lilly is recognized for its commitment to research and development in the healthcare sector.
Latest news from Eli Lilly And Company
Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health
September 15, 2026
Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
September 11, 2026
Obesity Market Set for Explosive 27% CAGR Growth by 2036, Fueled by 7 Promising Emerging Therapies | DelveInsight
September 10, 2026
Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials
September 8, 2026
Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Eli Lilly And Company earnings calls
Eli Lilly and Company (LLY) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Eli Lilly and Company (LLY) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Eli Lilly and Company (LLY) Q4 2025 Earnings Call
February 4, 2026 · Replay with transcript and chapters
Eli Lilly and Company (LLY) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Eli Lilly and Company (LLY) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Eli Lilly and Company (LLY) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Eli Lilly And Company
Eli Lilly And Company investor report
Review AI stock analysis and investor report context for LLY:NYSE.
Eli Lilly And Company company profile
View the public company page for Eli Lilly And Company on 6ix.
Eli Lilly And Company news
Read company news and market updates connected to Eli Lilly And Company.
Eli Lilly And Company investor events
Find investor webinars, events, and replay context for Eli Lilly And Company.
Alternate listings
LLY:GETTEX
DE · EUR
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY80:SET
TH · THB
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LILY:GPW
PL · PLN
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY:XETR
DE · EUR
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY:BCBA
AR · ARS
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LILY34:BMFBOVESPA
BR · BRL
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY:TRADEGATE
DE · EUR
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
858560:LSX
DE · EUR
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY:TSX
CA · CAD
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY:NEO
CA · CAD
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
LLY:BMV
MX · MXN
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.
1LLY:MIL
IT · EUR
Alternate listing for Eli Lilly And Company; the primary context on this page is LLY:NYSE.